Rare diseases
Investigational molecules
Locations
Diagnosvagen 11, Harlanda, 416 50 Gothenburg, Sweden
Sahlgrenska University Hospital in Gothenburg, Sweden specialises in clinical trials of conditions such as Prostate cancer, Neoplasm malignant, B-cell lymphoma recurrent, B-cell lymphoma refractory, and other specialisations. This site conducts important research.
At Sahlgrenska University Hospital the Kardiologen department conducts trials aimed at improving outcomes for patients with cardiovascular disease, including heart failure, hypertension, and atrial fibrillation. The studies evaluate new drug combinations, device therapies, and lifestyle interventions to reduce mortality and hospitalizations.
Overall, 38 trials involve 171 investigators, reflecting a strong focus on cardiovascular innovation at the site.
Research in this area explores genetic and developmental conditions affecting newborns and children, such as congenital heart disease and hereditary metabolic disorders. Trials assess gene‑modified T‑cell therapy and early‑intervention strategies to improve long‑term health.
The department collaborates with national registries to ensure comprehensive data collection for rare pediatric conditions.
Studies target chronic intestinal disorders, focusing on improving disease control and quality of life. Investigators evaluate novel biologics and small molecules for Crohn’s disease and primary sclerosing cholangitis.
These trials often incorporate patient‑reported outcomes to capture symptom relief.
The site conducts research on blood and lymphatic disorders, including cancers and clotting abnormalities. Projects examine targeted therapies for B‑cell malignancies and novel agents for haemophilia A.
Collaboration with hematology specialists supports rapid translation of laboratory findings to the clinic.
Clinical investigations address autoimmune and inflammatory conditions, testing agents that modulate immune pathways. Research includes therapies for autoimmune haemolytic anaemia and severe inflammatory myopathies.
The multidisciplinary team integrates rheumatology and immunology expertise to broaden therapeutic options.
Trials in this field focus on prostate cancer management and related urological conditions. Studies assess hormonal therapies, novel radiotherapy combinations, and genetic risk‑based interventions for prostate cancer.
Patient enrollment benefits from the hospital’s extensive urology network.
Research aims to restore joint function and reduce pain in degenerative conditions. Innovative tissue‑engineered implants and pharmacologic agents are evaluated for patellofemoral osteoarthritis and related disorders.
Outcomes include imaging, functional scores, and patient satisfaction metrics.
A broad oncology portfolio tackles solid tumors and hematologic malignancies, testing targeted agents, immunotherapies, and combination regimens. The goal is to improve survival and disease control across cancer types, including HER2‑positive breast cancer and KRAS G12C mutant non‑small cell lung cancer.
The site’s oncology unit contributes to international multicenter trials, enhancing access to cutting‑edge treatments.
Neurological research includes neurodegenerative and demyelinating disorders, focusing on disease‑modifying therapies. Trials investigate BTK inhibitors for multiple sclerosis and novel agents for glioblastoma.
Advanced imaging and biomarker analysis support precise assessment of treatment impact.
Investigations target chronic lung conditions and lung cancer, evaluating inhaled therapies, systemic agents, and supportive care strategies. The aim is to reduce exacerbations in chronic obstructive pulmonary disease and improve survival in small cell lung cancer.
Pulmonary specialists collaborate closely with oncology to manage overlapping disease processes.
Viral disease studies focus on prevention and treatment, including vaccine efficacy and antiviral therapies. A notable trial assesses a shingles vaccine in older adults, measuring effectiveness against herpes zoster.
The hospital’s infectious disease unit provides comprehensive follow‑up for vaccine safety.
Research explores lifestyle and behavioral interventions that influence health outcomes, such as physical activity programs and dietary counseling for cardiovascular risk reduction.
Interdisciplinary teams incorporate psychologists, physiotherapists, and nutritionists.
Clinical trials address mood and psychotic disorders, testing novel pharmacologic agents and adjunctive therapies to improve symptom control and functional recovery. Studies evaluate new treatments for bipolar depression and augmentation strategies for resistant depression.
Psychiatric expertise ensures rigorous monitoring of mental health endpoints.
More sites in GothenburgSweden
Clinical trials currently enrolling participants at this site.
SwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenSwedenMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
